Decrease in New Cancer Diagnoses Seen in 2020
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 28, 2023 -- There was a decrease in new cancer diagnoses in 2020, according to a report published online Sept. 27 in Cancer.
Serban Negoita, M.D., Dr.P.H., from the National Cancer Institute in Bethesda, Maryland, and colleagues examined changes in the counts of U.S. incident cases by cancer type, age, sex, race, and disease stage in 2020 using data extracted from selected U.S. population-based cancer registries for diagnosis years 2015 to 2020. The monthly numbers of newly diagnosed cancer cases were extracted for colorectal, female breast, lung, pancreas, prostate, and thyroid cancer, and the ratio of observed-to-expected (O/E) incident cancer cases was calculated for 2020.
The authors found that for major screening-eligible cancer sites, the O/E ratio was <1.0, indicating fewer newly diagnosed cases than expected in 2020, with the lowest O/E ratios observed in April 2020. Asians/Pacific Islanders had the lowest O/E ratio for any race group for every cancer site except pancreas. Lower O/E ratios were seen for cases diagnosed at localized versus advanced stages.
"These missed opportunities for early cancer detection are alarming, particularly for those vulnerable populations that continue to face significant barriers in accessing cancer care," Monica M. Bertagnolli, M.D., director of the National Cancer Institute, said in a statement. "This report highlights the urgency in helping all Americans get back on track with their cancer care so that we can avoid unnecessary deaths and complications from cancer."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.